487 related articles for article (PubMed ID: 12415954)
21. Antithyroid drugs and radioactive iodine. Fifteen years' experience with Graves' disease.
Reynolds LR; Kotchen TA
Arch Intern Med; 1979 Jun; 139(6):651-3. PubMed ID: 87156
[TBL] [Abstract][Full Text] [Related]
22. [Serum thyroxine and triiodothyronine levels after a single dose and after 2-month-long thiamazole treatment of Graves' disease with reference to drug's pharmacokinetics].
Syrenicz A
Ann Acad Med Stetin; 1990; 36():133-52. PubMed ID: 2099104
[TBL] [Abstract][Full Text] [Related]
23. [Treatment of hyperthyroidism caused by Graves' disease or toxic multinodular goitre by radioiodine: over 80% cure retrospectively after one calculated dose].
Bakker SC; Zanin DE; Zweers EJ
Ned Tijdschr Geneeskd; 2002 Sep; 146(39):1837-41. PubMed ID: 12382370
[TBL] [Abstract][Full Text] [Related]
24. The efficacy of thyroidectomy for Graves' disease: A meta-analysis.
Palit TK; Miller CC; Miltenburg DM
J Surg Res; 2000 May; 90(2):161-5. PubMed ID: 10792958
[TBL] [Abstract][Full Text] [Related]
25. Risk of recurrence at the time of withdrawal of short- or long-term methimazole therapy in patients with Graves' hyperthyroidism: a randomized trial and a risk-scoring model.
Azizi F; Amouzegar A; Khalili D; Abdi H; Tohidi M; Hedayati M; Cheraghi L; Mehrabi Y; Takyar M
Endocrine; 2024 May; 84(2):577-588. PubMed ID: 38165576
[TBL] [Abstract][Full Text] [Related]
26. Medical therapy of Graves' disease: effect on remission rates of methimazole alone and in combination with triiodothyronine.
Raber W; Kmen E; Waldhäusl W; Vierhapper H
Eur J Endocrinol; 2000 Feb; 142(2):117-24. PubMed ID: 10664518
[TBL] [Abstract][Full Text] [Related]
27. [Hyperthyroidism in children (author's transl)].
Lorini R; Larizza D; Bozzola M; Livieri C; Cisternino M; Salvatoni A; Severi F
Pediatr Med Chir; 1981; 3(1):41-4. PubMed ID: 6170957
[TBL] [Abstract][Full Text] [Related]
28. Prediction of remission or relapse for Graves' hyperthyroidism by the combined determination of stimulating, blocking and binding TSH-receptor antibodies after the withdrawal of antithyroid drug treatment.
Wallaschofski H; Miehle K; Mayer A; Tuschy U; Hentschel B; Paschke R
Horm Metab Res; 2002 Jul; 34(7):383-8. PubMed ID: 12189586
[TBL] [Abstract][Full Text] [Related]
29. Short-term antithyroid drug therapy for the thyrotoxicosis of Graves's disease.
Greer MA; Kammer H; Bouma DJ
N Engl J Med; 1977 Jul; 297(4):173-6. PubMed ID: 69269
[TBL] [Abstract][Full Text] [Related]
30. [Retrospective studies of the long-term course of various forms of hyperthyroidism with special reference to prognostic aspects].
Keil I; Nahrendorf T; Hüller M; Schambach H
Z Gesamte Inn Med; 1989 Nov; 44(22):677-81. PubMed ID: 2483282
[TBL] [Abstract][Full Text] [Related]
31. Correction of insulin resistance in methimazole-treated patients with Graves disease.
Tene C; Zárate A; Basurto L; Islas S; Revilla C; Ochoa R; Galván R; Santos P
Rev Invest Clin; 2001; 53(6):531-5. PubMed ID: 11921526
[TBL] [Abstract][Full Text] [Related]
32. [Evaluation of the results of treatment of Graves' disease by synthetic antithyroid drugs].
Fischer D; Poncin J; Dunet R; Dry J; Thomas M
Sem Hop; 1977 Oct 9-16; 53(34-35):1843-9. PubMed ID: 73224
[TBL] [Abstract][Full Text] [Related]
33. [Treatment of Basedow-Graves' hyperthyroidism: retrospective analysis after 30 years].
Pineda G; Arancibia P; Mejía G
Rev Med Chil; 1998 Aug; 126(8):953-62. PubMed ID: 9830747
[TBL] [Abstract][Full Text] [Related]
34. Outcome of Graves' disease after antithyroid drug treatment in Taiwan.
Wang PW; Liu RT; Tung SC; Chien WY; Lu YC; Chen CH; Kuo MC; Hsieh JR; Wang ST
J Formos Med Assoc; 1998 Sep; 97(9):619-25. PubMed ID: 9795530
[TBL] [Abstract][Full Text] [Related]
35. Long-term follow-up study of compensated low-dose 131I therapy for Graves' disease.
Sridama V; McCormick M; Kaplan EL; Fauchet R; DeGroot LJ
N Engl J Med; 1984 Aug; 311(7):426-32. PubMed ID: 6205272
[TBL] [Abstract][Full Text] [Related]
36. [Hyperthyroidism in childhood].
Lombardo G; De Luca F; Trimarchi F; Bianchi C
Pediatr Med Chir; 1983; 5(6):485-92. PubMed ID: 6085155
[TBL] [Abstract][Full Text] [Related]
37. Serum free triiodothyronine to free thyroxine ratio enables early prediction of the outcome of antithyroid drug therapy in patients with Graves' hyperthyroidism.
Tajiri J; Noguchi S; Morita M; Tamaru M; Murakami N; Kato R
Endocrinol Jpn; 1991 Dec; 38(6):683-7. PubMed ID: 1726635
[TBL] [Abstract][Full Text] [Related]
38. Frequency of antineutrophil cytoplasmic antibody in Graves' disease patients treated with methimazole.
Gumà M; Salinas I; Reverter JL; Roca J; Valls-Roc M; Juan M; Olivé A
J Clin Endocrinol Metab; 2003 May; 88(5):2141-6. PubMed ID: 12727967
[TBL] [Abstract][Full Text] [Related]
39. [Basedow-Graves' disease: analysis of various parameters in the prognosis of remission after clinical treatment].
Dias Júnior AA; Scalissi NM; Marone MM; Correa PH; Bianco AC
Rev Paul Med; 1989; 107(2):69-74. PubMed ID: 2629056
[TBL] [Abstract][Full Text] [Related]
40. Factors at onset predictive of lasting remission in pediatric patients with Graves' disease followed for at least three years.
Mussa GC; Corrias A; Silvestro L; Battan E; Mostert M; Mussa F; Pellegrino D
J Pediatr Endocrinol Metab; 1999; 12(4):537-41. PubMed ID: 10417970
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
